Literature DB >> 32706271

Mega Fibula Free Flap for Reconstruction of an Extensive Mandibulofacial Defect.

Chen Lin1, Akina Tamaki1, Enver Ozer1.   

Abstract

OBJECTIVE: Extensive mandibulofacial defects can be challenging to reconstruct. We present the case of a complex mandibulofacial defect reconstructed with a mega, chimeric fibula free flap.
METHODS: Ablation of the oral cavity tumor resulted in a large defect involving mandible, floor of mouth, and tongue. Skin of the chin and neck as well as the lower lip were also resected. A fibula free flap was harvested with the skin paddle involving most of the lateral compartment.
RESULTS: The fibula free flap was split into proximal (80 cm2) and distal (120 cm2) skin paddle islands, which were supplied by separate perforators off the peroneal artery. The intraoral soft tissue defect was reconstructed with the proximal skin paddle while the skin was recreated with the distal skin paddle. A Karapandzic flap was used to reconstruct the lower lip.
CONCLUSIONS: The traditional fibula free flap skin paddle often does not provide sufficient soft tissue coverage for large mandibulofacial defects. Some surgeons opt to harvest a second free flap. We describe our technique for using the mega fibula free flap - one of the largest reported in the literature - as a single mode of reconstruction.

Entities:  

Keywords:  double island skin paddle; fibula free flap; mandibulofacial defect; oral cavity reconstruction

Mesh:

Year:  2020        PMID: 32706271     DOI: 10.1177/0003489420946782

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  1 in total

1.  Superficial Temporal Artery and Vein as Alternative Recipient Vessels for Intraoral Reconstruction With Free Flaps to Avoid the Cervical Approach With the Resulting Need for Double Flap Transfer in Previously Treated Necks.

Authors:  Lucas M Ritschl; Minli Niu; Katharina Pippich; Philia Schuh; Niklas Rommel; Andreas M Fichter; Klaus-Dietrich Wolff; Jochen Weitz
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.